VA Palo Alto Lucile Packard Children's Hospital Stanford Hospital & Clinics Stanford University Santa Clara Valley Medical Departments Institutes School Home Stanford School of Medicine
MolePharm Site Only
Stanford Medicine
Department of Molecular Pharmacology
Application Maintenance Underway - Stanford University School of Medicine

Maintenance Currently Underway

We are sorry, the system you attemped to access is currently unavailable.

Maintenance Status

The system is unavailable during upgrade maintenance.
We expect service to be restored shortly.

Please try back.

William Weis Info

>
>
>
>

Find a Profile

>
>
  Help
Update Your Profile
SUNet ID required
 

William Weis

Academic Appointments
Appointment
Organization
Professor
Professor
Member
Graduate & Fellowship Program Affiliations
 
Administrative Appointments
Title
Organization
Start Year
End Year

Director
Graduate Program in Biophysics
1999
-

Professional Education
Degree
Awarding Institution
Field of Study
Year of Graduation

A.B.
Princeton University
Biochemical Sciences
1981
Ph.D.
Harvard University
Biochemistry
1988
Research Interests

Cadherin-based adhesion

Several distinct intercellular junctions connect epithelial cells. Two of these, the adherens junction and the desmosome, contain cadherin cell adhesion molecules. The extracellular regions of these transmembrane proteins mediate intercellular binding, while their cytoplasmic domains are linked to the actin- (adherens junction) or intermediate filament- (desmosome) based cytoskeletons. In this way the cytoskeletons of cells comprising a tissue are linked, imparting particular morphologies and mechanical strength to the tissue. The dynamics of these complex assemblies underlie changes in cell and tissue architecture that occur during development and in many cancers. Our research aims to understand the 3-dimensional architecture and dynamics of these junctions.

Wnt signaling
The Wnt signaling pathway controls cell fate determination during embryogenesis and in the normal renewal of tissues in the adult. beta-catenin is the central component of this pathway, where it serves as a transcriptional coactivator. In the absence of a secreted Wnt protein, non-junctional beta-catenin is bound in a multiprotein “destruction complex”. Formation of this complex promotes phosphorylation of beta-catenin, which targets it for degradation by the ubiquitin/proteosome pathway. Binding of a Wnt to cell surface receptors prevents phosphorylation of beta-catenin. The resulting stabilized beta-catenin enters the nucleus and activates transcription of Wnt target genes through its interactions with Tcf-family transcription factors, proteins that contain a beta-catenin-binding domain and a sequence-specific DNA-binding domain.

We are trying to understand the mechanisms by which formation of the destruction complex enhances the phosphorylation of ?-catenin, and how beta-catenin serves as a scaffold to link the sequence-specific Tcfs to components of the general transcription machinery. We are attempting to biochemically reconstitute these complexes for mechanistic and structural studies.

Intracellular vesicle trafficking
The directed movement of membranous vesicles is essential for maintaining the compartmentalized structure of the eukaryotic cell. The machinery responsible for this process is highly conserved amongst different intracellular trafficking pathways and amongst eukaryotes. An important example is the delivery of vesicles to particular regions of the plasma membrane, which is essential for maintaining the structure of polarized cells. We are studying proteins involved in the regulated movement, docking, and fusion of vesicles with their target membranes.

Carbohydrate-based adhesion
We study specificity and mechanism in the C-type animal lectins, a large family of Ca2+-depdendent carbohydrate binding proteins. Our studies are focused on two members of this family involved in the innate and adaptive immune response.
1. DC-SIGN is a C-type lectin found on the surface of dendritic cells that is thought to mediate the binding of dendritic cells to T cells in secondary lymphoid organs. It also has a well-documented role as a receptor for HIV. It is thought that high-mannose oligosaccharides present on the HIV surface protein gp120 bind to DC-SIGN present on the surface of dendritic cells resident in mucosal tissues at sites of HIV exposure, and transit with the dendritic cells to the secondary lymphoid organs, where it is delivered to CD4+ T cells.

2. Mannose-binding proteins (MBPs) are serum proteins that recognize carbohydrate structures present on pathogens, and trigger killing of these organisms via the complement pathway. MBPs circulate as a complex with MBP-associated serine proteases (MASPs). Upon binding to a cell surface, the inactive MASP zymogen is activated, which then triggers downstream components of the complement cascade. Our studies aim to understand how binding to a target surface results in conformational rearrangements required for zymogen activation.

Publications
  • Hattendorf DA, Andreeva A, Gangar A, Brennwald PJ, Weis WI "Structure of the yeast polarity protein Sro7 reveals a SNARE regulatory mechanism." Nature 2007; 446: 7135: 567-71 More »
  • Feinberg H, Taylor ME, Weis WI "Scavenger receptor C-type lectin binds to the leukocyte cell surface glycan Lewis x by a novel mechanism." J Biol Chem 2007; More »
  • Pokutta S, Weis WI "Structure and Mechanism of Cadherins and Catenins in Cell-Cell Contacts." Annu Rev Cell Dev Biol 2007; More »
  • Kwiatkowski AV, Weis WI, Nelson WJ "Catenins: playing both sides of the synapse." Curr Opin Cell Biol 2007; 19: 5: 551-6 More »
  • Day PW, Rasmussen SG, Parnot C, Fung JJ, Masood A, Kobilka TS, Yao XJ, Choi HJ, Weis WI, Rohrer DK, Kobilka BK "A monoclonal antibody for G protein-coupled receptor crystallography." Nat Methods 2007; 4: 11: 927-9 More »
69 publications:   view full list